Jianyu Weng - Concepedia

Author

Jianyu Weng

Guangdong Academy of Medical Sciences ORCID

Also Known As

J Weng, J Y Weng, Jian-Yu Weng, Jian-yu Weng, JianYu Weng, Jianyu Weng, Jian‐Yu Weng, Jian‐yu Weng, Weng J, Weng, Jianyu

172

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Guangdong Academy of Medical Sciences Guangdong General Hospital Guangdong Provincial People's Hospital Sun Yat-sen University Jinan University

About

Jianyu Weng is an author at Guangdong Academy of Medical Sciences specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	674
2	Cell Biology	6	6	238
3	Health Sciences	2	2	251
4	Biochemistry	1	1	12
5	Cellular Physiology	1	1	12

Jianyu Weng

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD Jianyu Weng, Xin Du, Suxia Geng, Bone Marrow Transplantation Cell TherapyImmunodeficienciesImmunologyCell Replacement TherapyImmunotherapeutics	2010	238
Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma Zhiwu Jiang, Xiaofeng Jiang, Suimin Chen, Frontiers in Immunology	2017	205
A potent immunomodulatory role of exosomes derived from mesenchymal stromal cells in preventing cGVHD Peilong Lai, Xiaomei Chen, Liyan Guo, Journal of Hematology & Oncology	2018	186
The Fas-Fas ligand system and other modulators of apoptosis in the cornea. Steven E. Wilson, Qiang Li, Jianyu Weng, PubMed	1996	182
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial George R. Thompson, Àlex Soriano, Oliver A. Cornely, The Lancet Translational MedicineAntifungal AgentAntifungal AgentsRezafungin Versus CaspofunginRandomised Phase 3	2022	150
A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia Jianyu Weng, Peilong Lai, Le Qin, Journal of Hematology & Oncology	2018	124
Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells Yunxin Lai, Jianyu Weng, Xuefeng Wei, Leukemia InflammationToll-like ReceptorsCar T CellsCancer ImmunosurveillanceT-regulatory Cell	2017	103
Incorporation of a hinge domain improves the expansion of chimeric antigen receptor T cells Le Qin, Yunxin Lai, Ruocong Zhao, Journal of Hematology & Oncology	2017	95
Mesenchymal Stromal Cells Treatment Attenuates Dry Eye in Patients With Chronic Graft-versus-host Disease Jianyu Weng, Chang He, Peilong Lai, Molecular Therapy	2012	86
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial Ke Zhao, Ren Lin, Zhiping Fan, Journal of Hematology & Oncology	2022	84

Page 1